This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

First IMRIS Intraoperative Suite In Canada Featuring Flexibility Of MRI And Angiography Opens At Health Sciences Centre Winnipeg

Stocks in this article: IM IMRS

Neurosurgeons can image, treat patients within three-room suite without moving patients

WINNIPEG, Sept. 17, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the official opening of the first VISIUS ® Surgical Theatre in Canada that features both intraoperative MRI (iMRI) and angiography capability together in a three-room suite at Health Sciences Centre Winnipeg.

"As Manitoba's center for trauma and neurosciences, the IMRIS suite enhances our surgical and diagnostic expertise and gives us an important technology platform that is an integral part of emerging therapies and procedures that advance patient care," said Dr. Neil Berrington, Head of Neurosurgery at HSC Winnipeg. "It's a powerful part of the Centre for Surgical Innovation in our new Kleysen Institute for Advanced Medicine and raises the bar in bringing together neurosurgical research and improved patient outcomes."

The VISIUS Surgical Theatre features an MR scanner and an interventional bi-plane angiography system. Mounted on ceiling rails for on-demand movement, the MR scanner can be deployed into any of three rooms - permitting rapid and efficient transitions between MR imaging and surgery or intervention without transporting the patient between modalities.

MR images can be taken before and during procedures to assess tissue condition, and can also be used in conjunction with fluoroscopic images during neurovascular procedures. When not in use for intraoperative imaging, both the MR and fluoroscopic system are available for diagnostic use as well.

The largest hospital in Winnipeg, HSC Winnipeg is the fourth Canadian institution to install a VISIUS Surgical Theatre and one of five in North America with a combined iMRI and angiography suite, providing multi-modality image guidance capabilities to assist clinicians in improving outcomes for patients during neurosurgical and interventional procedures. The angiography capability will assist surgeons with neurovascular procedures such as stroke management.

IMRIS CEO Jay D. Miller said this is a big step for healthcare in Manitoba and Canada. "The combined benefits of the IMRIS solution will assist in addressing a broad range of neurological disorders. As a company founded in Winnipeg, Manitoba, we are delighted that our solutions will be contributing to proven reductions in re-operation rates," he said.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 54 leading medical institutions around the world.

SOURCE IMRIS Inc.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,088.01 +57.80 0.32%
S&P 500 2,091.31 +9.43 0.45%
NASDAQ 4,808.5230 +35.0510 0.73%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs